All Relations between dopaminergic and Neurodegenerative Diseases

Publication Sentence Publish Date Extraction Date Species
Yuanzhang Zhou, Yang Liu, Zhengwei Kang, Hang Yao, Nanshan Song, Min Wang, Chenghuan Song, Kezhong Zhang, Jianhua Ding, Juanjuan Tang, Gang Hu, Ming L. Autophagy. 2023-04-04. PMID:37014258. despite growing evidence that has declared the importance of circrnas in neurodegenerative diseases, the clinical significance of circrnas in dopaminergic (da) neuronal degeneration in the pathogenesis of parkinson disease (pd) remains unclear. 2023-04-04 2023-08-14 Not clear
Feng Qiu, Yue Wu, Guojin Xie, Hui Cao, Mingyang Du, Haibo Jian. MiRNA-1976 Regulates the Apoptosis of Dopaminergic Neurons by Targeting the Journal of integrative neuroscience. vol 22. issue 2. 2023-03-30. PMID:36992582. mirna-1976 regulates the apoptosis of dopaminergic neurons by targeting the parkinson's disease (pd), which is a neurodegenerative disease, requires urgently needed biomarkers to explore its mechanism. 2023-03-30 2023-08-14 Not clear
Mohammed Alrouji, Hayder M Al-Kuraishy, Ali I Al-Gareeb, Hebatallah M Saad, Gaber El-Saber Batih. A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson's disease: beneficial or detrimental effects. Inflammopharmacology. 2023-03-24. PMID:36961665. parkinson's disease (pd) is an advanced neurodegenerative disease (ndd) caused by the degeneration of dopaminergic neurons (dns) in the substantia nigra (sn). 2023-03-24 2023-08-14 Not clear
Sena Boncuk Ulaş, Yeşim Güzey Aras, Sezen Irmak Gözükara, Türkan Acar, Bilgehan Atılgan Aca. Correlates of Zonulin and Claudin-5, markers of intestinal and brain endothelial permeability, in Parkinson's Disease: A pilot study. Parkinsonism & related disorders. vol 110. 2023-03-24. PMID:36963340. idiopathic parkinson's disease is a chronic, progressive, neurodegenerative disease that affects the substantia nigra pars compacta and dopaminergic neurons in the brain stem. 2023-03-24 2023-08-14 Not clear
Hongli Li, Min Gao, Ziyu Chen, Zhenyu Zhou, Wei Li, Xiaoyang Zhang, Xi Jiang, Lingling Luo, Fei Li, Gaorui Wang, Yu Zhang, Xingxu Huang, Jingning Zhu, Shengjie Fan, Xiaojun Wu, Cheng Huan. Hordenine improves Parkinsonian-like motor deficits in mice and nematodes by activating dopamine D2 receptor-mediated signaling. Phytotherapy research : PTR. 2023-03-08. PMID:36883794. parkinson's disease (pd) is a chronic neurodegenerative disease characterized by selective loss of dopaminergic neurons in the substantia nigra pars compacta (snpc) and the striatum, leading to dopamine (da) deficiency in the striatum and typical motor symptoms. 2023-03-08 2023-08-14 mouse
Jeyaram Bharathi J, Nagarjuna Palathoti, Muralikrishnan Dhanasekaran, R Sivasamy, Sivasankaran Ponnusankar, S P Dhanabal, V Sankar, Antony Justi. Neurotrophin mimetics and tropomyosin kinase receptors: a futuristic pharmacological tool for Parkinson's. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2023-03-04. PMID:36870001. parkinson's disease is a complex age-related progressive dopaminergic neurodegenerative disease consistently viewed as a disorder of movement and is characterized by its cardinal motor symptoms. 2023-03-04 2023-08-14 Not clear
Yufang Yao, Zhiyue Zhao, Fubo Zhang, Na Miao, Nan Wang, Xin Xu, Chaoping Yan. microRNA-221 rescues the loss of dopaminergic neurons in a mouse model of Parkinson's disease. Brain and behavior. 2023-02-16. PMID:36795044. parkinson's disease (pd) is one of the most common systemic neurodegenerative diseases and is related to the loss of dopaminergic neurons in the substantia nigra. 2023-02-16 2023-08-14 mouse
Tatiana Gerasimova, Ekaterina Stepanenko, Lyudmila Novosadova, Elena Arsenyeva, Darya Shimchenko, Vyacheslav Tarantul, Igor Grivennikov, Valentina Nenasheva, Ekaterina Novosadov. Glial Cultures Differentiated from iPSCs of Patients with International journal of molecular sciences. vol 24. issue 3. 2023-02-11. PMID:36768317. glial cultures differentiated from ipscs of patients with parkinson's disease (pd) is the second most common neurodegenerative diseases characterized by progressive loss of midbrain dopaminergic neurons in the substantia nigra. 2023-02-11 2023-08-14 Not clear
Jiewen Qiu, Guoyou Peng, Yuting Tang, Shiyin Li, Zengfu Liu, Jiayun Zheng, Yunxin Wang, Hanqun Liu, Lijian Wei, Yilin Su, Yuwan Lin, Wei Dai, Zhiling Zhang, Xiang Chen, Liuyan Ding, Wenyuan Guo, Xiaoqin Zhu, Pingyi Xu, Mingshu M. Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson's disease. Frontiers in aging neuroscience. vol 14. 2023-02-06. PMID:36742201. parkinson's disease (pd) is a progressive neurodegenerative disease with characteristic pathological abnormalities, including the loss of dopaminergic (da) neurons, a dopamine-depleted striatum, and microglial activation. 2023-02-06 2023-08-14 rat
Jessica K Smith, George D Mellick, Alex M Syke. The role of the endolysosomal pathway in α-synuclein pathogenesis in Parkinson's disease. Frontiers in cellular neuroscience. vol 16. 2023-01-27. PMID:36704248. parkinson's disease (pd) is a chronic neurodegenerative disease that is characterized by a loss of dopaminergic neurons in the substantia nigra pars compacta of the midbrain (snpc). 2023-01-27 2023-08-14 Not clear
Marco Travaglio, Filippos Michopoulos, Yizhou Yu, Rebeka Popovic, Edmund Foster, Muireann Coen, L Miguel Martin. Increased cysteine metabolism in PINK1 models of Parkinson's disease. Disease models & mechanisms. vol 16. issue 1. 2023-01-25. PMID:36695500. parkinson's disease (pd), an age-dependent neurodegenerative disease, is characterised by the selective loss of dopaminergic neurons in the substantia nigra (sn). 2023-01-25 2023-08-14 human
Yuting Sun, Jianglong Kong, Xiaohan Ge, Meiru Mao, Hongrui Yu, Yi Wan. An Antisense Oligonucleotide-Loaded Blood-Brain Barrier Penetrable Nanoparticle Mediating Recruitment of Endogenous Neural Stem Cells for the Treatment of Parkinson's Disease. ACS nano. 2023-01-23. PMID:36688425. parkinson's disease (pd) is a neurodegenerative disease characterized by the death of dopaminergic (da) neurons and currently cannot be cured. 2023-01-23 2023-08-14 Not clear
Yue Wu, Zhongting Zhao, Naidi Yang, Chenqi Xin, Zheng Li, Jiajia Xu, Bo Ma, Kah-Leong Lim, Lin Li, Qiong Wu, Changmin Yu, Chengwu Zhan. Vitamin B12 Ameliorates the Pathological Phenotypes of Multiple Parkinson's Disease Models by Alleviating Oxidative Stress. Antioxidants (Basel, Switzerland). vol 12. issue 1. 2023-01-21. PMID:36671015. parkinson's disease (pd) is the second most common neurodegenerative disease characterized by progressive loss of dopaminergic neurons in the substantia nigra of the midbrain. 2023-01-21 2023-08-14 Not clear
Minyoung Oh, Juhyeon Nam, Areum Baek, Ji-Hye Seo, Jung-Il Chae, Seo-Young Lee, Sun-Ku Chung, Byoung Chul Park, Sung Goo Park, Janghwan Kim, Young-Joo Jeo. Neuroprotective Effects of Licochalcone D in Oxidative-Stress-Induced Primitive Neural Stem Cells from Parkinson's Disease Patient-Derived iPSCs. Biomedicines. vol 11. issue 1. 2023-01-21. PMID:36672736. parkinson's disease (pd) is one of the most common neurodegenerative diseases caused by the loss of dopaminergic neurons in the substantia nigra pars compacta. 2023-01-21 2023-08-14 Not clear
Nicola Paccione, Mahdieh Rahmani, Emilia Barcia, Sofía Negr. Antiparkinsonian Agents in Investigational Polymeric Micro- and Nano-Systems. Pharmaceutics. vol 15. issue 1. 2023-01-21. PMID:36678642. parkinson's disease (pd) is a devastating neurodegenerative disease characterized by progressive destruction of dopaminergic tissue in the central nervous system (cns). 2023-01-21 2023-08-14 Not clear
Meimei Xing, Guoyun Li, Yang Liu, Luyao Yang, Youjiao Zhang, Yuruo Zhang, Jianhua Ding, Ming Lu, Guangli Yu, Gang H. Fucoidan from Fucus vesiculosus prevents the loss of dopaminergic neurons by alleviating mitochondrial dysfunction through targeting ATP5F1a. Carbohydrate polymers. vol 303. 2023-01-19. PMID:36657849. parkinson's disease is a neurodegenerative disease that is characterized by the loss of dopaminergic neurons. 2023-01-19 2023-08-14 mouse
Tian-Kuo Lee, K Ashok Kumar, Chih-Yang Huang, Po-Hsiang Liao, Tsung-Jung Ho, Wei-Wen Kuo, Shih-Chieh Liao, Dennis Jine-Yuan Hsieh, Ping-Ling Chiu, Yung-Ming Chang, Da-Tong J. Garcinol protects SH-SY5Y cells against MPP+-induced cell death by activating DJ-1/SIRT1 and PGC-1α mediated antioxidant pathway in sequential stimulation of p-AMPK mediated autophagy. Environmental toxicology. 2023-01-11. PMID:36629037. parkinson's disease (pd), a chronic and progressive neurodegenerative disease, can reduce the population of dopaminergic neurons in the substantia nigra. 2023-01-11 2023-08-14 human
Bruk Getachew, Antonei B Csoka, Robert L Copeland, Kebreten F Manaye, Yousef Tizab. Dihydromyricetin Protects Against Salsolinol-Induced Toxicity in Dopaminergic Cell Line: Implication for Parkinson's Disease. Neurotoxicity research. 2022-12-30. PMID:36585544. parkinson's disease (pd) is a progressive neurodegenerative disease associated with loss of dopaminergic neurons in the substantia nigra pars compacta. 2022-12-30 2023-08-14 human
Xing-Jie Xu, Tao Pan, Hui-Jie Fan, Xu Wang, Jie-Zhong Yu, Hai-Fei Zhang, Bao-Guo Xiao, Zhen-Yu Li, Bo Zhang, Cun-Gen Ma, Zhi Cha. Neuroprotective effect of hyperoside in MPP Metabolic brain disease. 2022-12-28. PMID:36576692. neuroprotective effect of hyperoside in mpp parkinson's disease (pd) is a neurodegenerative disease characterized by the pathological loss of nigrostriatal dopaminergic neurons, which causes an insufficient release of dopamine (da) and then induces motor and nonmotor symptoms. 2022-12-28 2023-08-14 Not clear
Giselle Prunell, Silvia Olivera-Brav. A Focus on Astrocyte Contribution to Parkinson's Disease Etiology. Biomolecules. vol 12. issue 12. 2022-12-23. PMID:36551173. parkinson's disease (pd) is an incurable neurodegenerative disease of high prevalence, characterized by the prominent death of dopaminergic neurons in the substantia nigra pars compacta, which produces dopamine deficiency, leading to classic motor symptoms. 2022-12-23 2023-08-14 Not clear